Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQNF41
|
|||
| Drug Name |
Mesdopetam
|
|||
| Synonyms |
mesdopetam; IRL790; IRL-790; HD4QV8GX26; 1403894-72-3; UNII-HD4QV8GX26; N-[2-(3-fluoro-5-methylsulfonylphenoxy)ethyl]propan-1-amine; 1-Propanamine, N-(2-(3-fluoro-5-(methylsulfonyl)phenoxy)ethyl)-; MESDOPETAM [INN]; MESDOPETAM [WHO-DD]; CHEMBL4594447; SCHEMBL13732678; GTPL10811; OSBPYFBXSLJHCR-UHFFFAOYSA-N; AKOS040756735; HY-109150; CS-0115974; N-[2-(3-FLUORO-5-METHYLSULFONYL-PHENOXY)ETHYL]PROPAN-1-AMINE; N-{2-[3-FLUORO-5-(METHYLSULFONYL)PHENOXY]ETHYL}-N-PROPYLAMINE
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 2 | [1] | |
| Company |
Integrative Research Laboratories AB
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H18FNO3S
|
|||
| Canonical SMILES |
CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F
|
|||
| InChI |
InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3
|
|||
| InChIKey |
OSBPYFBXSLJHCR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04435431) A Randomized, Double-blind, Placebo-controlled Phase IIB Study Evaluating the Efficacy of Mesdopetam on Daily ON-time Without Troublesome Dyskinesia in Patients With Parkinson's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.